The Gab2 docking protein acts as an important signal amplifier downstream of various growth factor receptors and Bcr-Abl, the driver of chronic myeloid leukaemia (CML). This evidence concerns the gene GAB2 and chronic myelogenous leukemia, BCR-ABL1 positive.